Top Markets
#1 EXOD EXOD +22.78%
#2 Status Status +8.56%
#3 Tornado Cash Tornado Cash +4.89%
#4 Ontology Gas Ontology Gas +4.17%
#5 The Black Bull The Black Bull +2.72%
#6 HOME HOME +2.58%
#7 Anvil Anvil +2.51%
#8 Velvet Velvet +2.28%
#9 Fractal Bitcoin Fractal Bitcoin +2.26%
#10 The Grays Currency The Grays Currency +2.17%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Aroa Biosurgery Limited Aroa Biosurgery Limited

Aroa Biosurgery Limited

ARX
Rank in Stocks #20202
Aroa Biosurgery Limited operates as a regenerative medicine company dedicated... Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.
Share Price
$0.39848591
Last synced: 2026-08-25
Market Cap
$137.67M
Change (1 day)
-1.74%
Change (1 year)
0.56%
Country
NZ
Trade Aroa Biosurgery Limited (ARX)

Category

Healthcare
Operating Margin for Aroa Biosurgery Limited (ARX)
Operating Margin as of 2026 TTM: 0.00%
According to Aroa Biosurgery Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Aroa Biosurgery Limited from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.